BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• Business

  Surgery Partners, Inc. Announces Fourth Quarter and Full Year 2021 Results; Raises 2022 Guidance

  Surgery Partners, Inc., a leading provider of surgical services, announced results for the fourth quarter and full year ended December 31, 2021.

  February 28, 2022

   · 

  21 min read
• Business

  Nuvation Bio Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update

  Nuvation Bio Inc. (NYSE: NUVB), a biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates, today reported financial results for the fourth quarter and full year ended December 31, 2021, and provided a business update.

  February 28, 2022

   · 

  9 min read
• Business

  CONMED Corporation Announces Quarterly Cash Dividend - Feb 28, 2022

  CONMED Corporation announced that its Board of Directors has declared a quarterly cash dividend of $0.20 per share, payable on April 5, 2022 to all shareholders of record as of March 15, 2022.

  February 28, 2022

   · 

  2 min read
• Business

  Baker to Retire From Ecolab Board

  Ecolab announced that Douglas M. Baker, Jr., executive chairman of the board of directors of Ecolab, has informed the company that he will step down from the board following the expiration of his current term at Ecolab’s 2022 Annual Meeting of Shareholders on May 5, 2022.

  February 28, 2022

   · 

  2 min read
• Business

  Enzolytics, Inc. Announces New Advisory Board Member

  Enzolytics, Inc. (OTC PINK:ENZC) ( https://enzolytics.com/ ) announces the addition of Dr. Suraj Kumar Saggar to its Advisory Board.

  February 28, 2022

   · 

  6 min read
• Drug Development

  Aptinyx Completes Enrollment in Phase 2b Study of NYX-2925 in Fibromyalgia

  Aptinyx Inc. today announced the completion of enrollment of 305 patients in the company’s ongoing Phase 2b study of NYX-2925 in fibromyalgia.

  February 28, 2022

   · 

  5 min read
• Business

  Singular Genomics Partners with QIAGEN to Enable QIAseq Kits for the G4 Sequencing Platform

  Singular Genomics Systems, Inc. today announced a partnership with QIAGEN to validate its QIAseq kits, a product line for both DNA and RNA sample prep, with the G4 sequencing platform.

  February 28, 2022

   · 

  4 min read
• Business

  Harmony Biosciences Reports Fourth Quarter and Full Year 2021 Financial Results and Business Updates

  Harmony Biosciences Holdings, Inc. today reported financial results and business updates for the fourth quarter and full year ended December 31, 2021.

  February 28, 2022

   · 

  20 min read
• Drug Development

  Adamis Pharmaceuticals’ Clinical Study Assessing Tempol for the Treatment of COVID-19 Surpasses Enrollment Expectations

  Adamis Pharmaceuticals Corporation (Nasdaq: ADMP) today announced that due to the acceleration of patient enrollment in the double-blind placebo controlled Phase 2/3 trial for Tempol for the treatment of COVID-19.

  February 28, 2022

   · 

  6 min read
• Genetown

  Syros to Participate in Upcoming Virtual Investor Conferences in March 2022

  Syros Pharmaceuticals, a leader in the development of medicines that control the expression of genes, announced that its Chief Executive Officer, Nancy Simonian, M.D., will participate in a panel discussion and present a corporate overview at two upcoming virtual investor conferences in March.

  February 28, 2022

   · 

  1 min read